CareRx Corporation

As of June 30, 2026, CareRx Corporation carries a market capitalization of 219.76M, placing it among publicly traded companies globally. Its enterprise value stands at 286.52M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CareRx Corporation's next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, CareRx Corporation has 63.51M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, CareRx Corporation maintains a current ratio of 1.08, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, CareRx Corporation recorded an income tax benefit of -22.02M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 22, 2026, CareRx Corporation's stock has declined approximately 5.38% over the past 52 weeks. The 50-day moving average sits at 3.23, while the 200-day moving average is 3.51.

As of June 30, 2026, CareRx Corporation holds 9.57M in cash and equivalents against 76.34M in total debt, resulting in a net debt position of 29.09M. Total book value stands at 109.60M, with working capital of 4.70M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, CareRx Corporation paid dividends of 0.06 per share.

CareRx Corporation's most recent stock split took place on June 25, 2020 with a 20:1 split ratio.